Xi‐Ding Yang
Impact in
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds
-
- Cancer-related molecular mechanisms research
Papers in
-
- Natural product bioactivities and synthesis 2
- Ubiquitin and proteasome pathways 1
- Co-authors
- Yong‐Yu Yang (11 shared papers)Guoping Yang (2 shared papers)Dongsheng Ouyang (1 shared paper)Daxiong Xiang (5 shared papers)Rongrong Deng (3 shared papers)Pingfei Fang (4 shared papers)Guangyao Zeng (1 shared paper)Chang‐Ping Hu (1 shared paper)
- Journals
- Drug Design Development and Therapy (2 papers)Frontiers in Endocrinology (2 papers)Fitoterapia (2 papers)Expert Opinion on Investigational Drugs (1 paper)Diabetes Obesity and Metabolism (1 paper)
- Partner nations
- China
In The Last Decade
Xi‐Ding Yang
17 papers receiving 608 citations
Peers
Comparison fields: 5 of 81
- Pharmacology 114
- Cancer Research 68
- Molecular Biology 336
- Biochemistry 27
- Geriatrics and Gerontology 12
Countries citing papers authored by Xi‐Ding Yang
This map shows the geographic impact of Xi‐Ding Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xi‐Ding Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xi‐Ding Yang more than expected).
Fields of papers citing papers by Xi‐Ding Yang
This network shows the impact of papers produced by Xi‐Ding Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xi‐Ding Yang. The network helps show where Xi‐Ding Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Xi‐Ding Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 226 | |
| 2 | 2022 | 87 | |
| 3 | 2014 | 70 | |
| 4 | 2021 | 48 | |
| 5 | 2019 | 38 | |
| 6 | 2024 | 33 | |
| 7 | 2016 | 32 | |
| 8 | 2021 | 26 | |
| 9 | 2022 | 21 | |
| 10 | 2024 | 14 | |
| 11 | 2021 | 12 | |
| 12 | 2023 | 4 | |
| 13 | 2024 | 3 | |
| 14 | 2014 | 3 | |
| 15 | 2021 | 3 | |
| 16 | 2023 | 2 | |
| 17 | 2018 | 2 | |
| 18 | 2024 | 0 |
About Xi‐Ding Yang
Xi‐Ding Yang is a scholar working on Molecular Biology, Cancer Research, Nephrology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism, having authored 18 papers that have together received 624 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (2 papers), Chronic Kidney Disease and Diabetes (2 papers), Natural product bioactivities and synthesis (2 papers), Phytochemicals and Antioxidant Activities (1 paper), Ubiquitin and proteasome pathways (1 paper), Inflammatory mediators and NSAID effects (1 paper), Blood groups and transfusion (1 paper) and Drug Transport and Resistance Mechanisms (1 paper). The work is most often cited by research in Pharmacology (114 citations), Cancer Research (68 citations), Molecular Biology (336 citations), Biochemistry (27 citations) and Geriatrics and Gerontology (12 citations). Xi‐Ding Yang has collaborated with scholars based in China. Frequent co-authors include Yong‐Yu Yang, Guoping Yang, Dongsheng Ouyang, Daxiong Xiang, Rongrong Deng, Pingfei Fang, Guangyao Zeng, Chang‐Ping Hu, Bing Xu and Yingjun Zhou. Their work appears in journals such as Drug Design Development and Therapy, Frontiers in Endocrinology, Fitoterapia, Expert Opinion on Investigational Drugs and Diabetes Obesity and Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.